
| ASSET | WEEK | % RETURN |
|---|---|---|
Xenetic Biosciences (XBIO) | 12/30/2013 - 1/5/2014 | 1,150% |
Scienture (SCNX) | 1/27/2014 - 2/2/2014 | 433.33% |
China Natural Resources (CHNR) | 12/30/2013 - 1/5/2014 | 173.42% |
Opus Genetics (IRD) | 1/6/2014 - 1/12/2014 | 115.09% |
Sobr Safe (SOBR) | 1/13/2014 - 1/19/2014 | 114.29% |
Capricor Therapeutics (CAPR) | 1/6/2014 - 1/12/2014 | 111.46% |
Sobr Safe (SOBR) | 1/27/2014 - 2/2/2014 | 109.86% |
Heritage Global (HGBL) | 12/30/2013 - 1/5/2014 | 109.68% |
SurgePays (SURG) | 1/27/2014 - 2/2/2014 | 100% |
Neurocrine Biosciences (NBIX) | 1/6/2014 - 1/12/2014 | 97.02% |
Galectin Therapeutics (GALT) | 1/6/2014 - 1/12/2014 | 82.59% |
BioRestorative Therapies (BRTX) | 1/6/2014 - 1/12/2014 | 77.76% |
Ainos (AIMD) | 1/20/2014 - 1/26/2014 | 73.33% |
Live Ventures (LIVE) | 1/6/2014 - 1/12/2014 | 71.29% |
GEE (JOB) | 1/27/2014 - 2/2/2014 | 67.86% |
GT Biopharma (GTBP) | 1/27/2014 - 2/2/2014 | 66.67% |
Fennec Pharmaceuticals (FENC) | 1/13/2014 - 1/19/2014 | 64.38% |
Live Ventures (LIVE) | 1/13/2014 - 1/19/2014 | 63.95% |
Savara (SVRA) | 1/13/2014 - 1/19/2014 | 63.46% |
Cytosorbents Crp (CTSO) | 1/20/2014 - 1/26/2014 | 61.26% |
Oramed Pharmaceuticals (ORMP) | 1/6/2014 - 1/12/2014 | 60.88% |
Creative Realities (CREX) | 1/20/2014 - 1/26/2014 | 58.32% |
Red Cat (RCAT) | 1/13/2014 - 1/19/2014 | 57.89% |
Capricor Therapeutics (CAPR) | 1/20/2014 - 1/26/2014 | 57.22% |
Enveric Biosciences (ENVB) | 1/6/2014 - 1/12/2014 | 56.88% |